| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural molecule activity | MYH8 H2AZ2 RPS5 MATN1 SPTAN1 TUBA3E PXDN COL2A1 H2AB2 KRT13 ANK2 KRT17 ANK3 CILP KRT19 LAMA2 LAMC1 VWA1 VWA5A TLN1 H1-2 H1-4 H2AZ1 | 4.00e-05 | 891 | 203 | 23 | GO:0005198 |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 1.03e-04 | 2 | 203 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | ADP binding | 1.24e-04 | 48 | 203 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 3.06e-04 | 3 | 203 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 3.06e-04 | 3 | 203 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 3.06e-04 | 3 | 203 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 3.06e-04 | 3 | 203 | 2 | GO:0019118 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | ABCC4 KDM5C CHDH P4HA3 RRM1 PGK1 PXDN GRHPR PDIA2 P4HA2 CYP26B1 ENOX1 MTHFD1L OGFOD2 RIOX1 AKR7L SDR42E2 AKR7A3 NNT | 3.19e-04 | 766 | 203 | 19 | GO:0016491 |
| GeneOntologyMolecularFunction | spectrin binding | 3.79e-04 | 34 | 203 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 4.30e-04 | 15 | 203 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 5.26e-04 | 16 | 203 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 5.99e-04 | 67 | 203 | 5 | GO:0031492 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 6.09e-04 | 4 | 203 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 MATN1 SPTAN1 PCDH17 HPGDS ANXA1 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 EYS SLC25A12 SUSD1 H1-4 CDH17 | 6.64e-04 | 749 | 203 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.95e-04 | 188 | 203 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | procollagen-proline 4-dioxygenase activity | 1.01e-03 | 5 | 203 | 2 | GO:0004656 | |
| GeneOntologyMolecularFunction | acyltransferase activity, acyl groups converted into alkyl on transfer | 1.01e-03 | 5 | 203 | 2 | GO:0046912 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 1.04e-03 | 20 | 203 | 3 | GO:0031418 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 DSCAML1 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 PALLD CDH17 | 3.17e-07 | 187 | 201 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | NRG1 DCHS2 DSCAML1 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 PALLD CDH17 | 1.30e-05 | 313 | 201 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | axon guidance | TRIO NFASC DSCAML1 NRXN3 SEMA6D SEMA6A ANK3 LAMA2 LAMC1 OPHN1 ULK2 PALLD | 2.46e-05 | 285 | 201 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | TRIO NFASC DSCAML1 NRXN3 SEMA6D SEMA6A ANK3 LAMA2 LAMC1 OPHN1 ULK2 PALLD | 2.55e-05 | 286 | 201 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NRG1 DCHS2 PKD1L1 NFASC TSC2 CCDC88B DSCAML1 PCDH17 NRXN3 PDIA2 ITCH ANK3 ANXA1 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 ST3GAL4 SPECC1L TLN1 PALLD CDH17 | 5.15e-05 | 1077 | 201 | 25 | GO:0098609 |
| GeneOntologyCellularComponent | cell-cell junction | MYH2 DCHS2 CNKSR1 SPTAN1 NFASC ABCB1 ABCB4 KIAA1210 SCN4B ANK2 ANK3 ANXA1 PCDHA12 PCDHA10 SPECC1L CDC42BPB TIAM1 TLN1 CDH17 | 5.80e-06 | 591 | 204 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | MYH2 DCHS2 ATP6V0C CNKSR1 RPS5 SPTAN1 NFASC ABCB1 ABCB4 KIAA1210 SCN4B HSPA8 ANK2 ANK3 ANXA1 PCDHA12 PCDHA10 SRCIN1 SPECC1L CDC42BPB SH3PXD2B TIAM1 TLN1 PALLD CDH17 | 1.04e-05 | 976 | 204 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell contact zone | 3.80e-05 | 94 | 204 | 7 | GO:0044291 | |
| GeneOntologyCellularComponent | myofibril | MYH2 MYH8 MYH13 SPTAN1 SQSTM1 ANK2 ANK3 KRT19 SYNE1 UNC45B PALLD | 8.10e-05 | 273 | 204 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH2 MYH8 MYH13 SPTAN1 SQSTM1 ANK2 ANK3 KRT19 SYNE1 UNC45B PALLD | 1.38e-04 | 290 | 204 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | paranodal junction | 1.43e-04 | 11 | 204 | 3 | GO:0033010 | |
| GeneOntologyCellularComponent | sarcomere | 1.75e-04 | 249 | 204 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH8 MYH13 SPTAN1 KIF9 ARSJ KRT19 ANXA1 ANKRD62 SRCIN1 SPECC1L CDC42BPB OPHN1 SH3PXD2B TTC17 PALLD | 1.78e-04 | 576 | 204 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | muscle myosin complex | 4.67e-04 | 16 | 204 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | paranode region of axon | 5.63e-04 | 17 | 204 | 3 | GO:0033270 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | CTSF MATN1 PXDN SEMA6D COL2A1 CILP ADAMTS1 ANXA1 RBP3 LAMA2 LAMC1 VWA1 EYS VWA5A | 7.42e-04 | 530 | 204 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | costamere | 1.23e-03 | 22 | 204 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | basement membrane | 1.27e-03 | 122 | 204 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 1.39e-03 | 6 | 204 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.39e-03 | 6 | 204 | 2 | GO:0033165 | |
| Domain | Cadherin_CS | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 3.23e-07 | 109 | 204 | 10 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 4.53e-07 | 113 | 204 | 10 | PS00232 |
| Domain | Cadherin | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 4.53e-07 | 113 | 204 | 10 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 4.92e-07 | 114 | 204 | 10 | PS50268 |
| Domain | - | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 4.92e-07 | 114 | 204 | 10 | 2.60.40.60 |
| Domain | CA | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 5.34e-07 | 115 | 204 | 10 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 5.78e-07 | 116 | 204 | 10 | IPR015919 |
| Domain | Cadherin | DCHS2 PCDH17 FAT3 PCDHB14 PCDHB12 PCDHB11 PCDHA12 PCDHA10 PCDHA7 CDH17 | 6.78e-07 | 118 | 204 | 10 | IPR002126 |
| Domain | Cadherin_2 | 6.81e-06 | 65 | 204 | 7 | PF08266 | |
| Domain | Cadherin_N | 6.81e-06 | 65 | 204 | 7 | IPR013164 | |
| Domain | TPR_REGION | 8.55e-05 | 165 | 204 | 9 | PS50293 | |
| Domain | TPR | 8.55e-05 | 165 | 204 | 9 | PS50005 | |
| Domain | PGLYCERATE_KINASE | 1.19e-04 | 2 | 204 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 1.19e-04 | 2 | 204 | 2 | IPR015824 | |
| Domain | - | 1.19e-04 | 2 | 204 | 2 | 3.40.50.1270 | |
| Domain | - | 1.19e-04 | 2 | 204 | 2 | 3.40.50.1260 | |
| Domain | PGK | 1.19e-04 | 2 | 204 | 2 | PF00162 | |
| Domain | DUF3715 | 1.19e-04 | 2 | 204 | 2 | IPR022188 | |
| Domain | Phosphoglycerate_kinase_CS | 1.19e-04 | 2 | 204 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 1.19e-04 | 2 | 204 | 2 | IPR015901 | |
| Domain | DUF3715 | 1.19e-04 | 2 | 204 | 2 | PF12509 | |
| Domain | ABC_membrane | 1.24e-04 | 24 | 204 | 4 | PF00664 | |
| Domain | Ankyrin_rpt | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 EXO1 ANKRD34C | 1.50e-04 | 262 | 204 | 11 | IPR002110 |
| Domain | ABC_transporter-like | 2.10e-04 | 50 | 204 | 5 | IPR003439 | |
| Domain | ABC_TM1F | 2.30e-04 | 28 | 204 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 2.30e-04 | 28 | 204 | 4 | IPR011527 | |
| Domain | TPR-contain_dom | 2.47e-04 | 150 | 204 | 8 | IPR013026 | |
| Domain | TPR-like_helical_dom | P4HA3 GPSM2 FKBP8 RGPD5 P4HA2 RGPD8 UNC45B TTC21B TTC17 SEL1L2 | 2.51e-04 | 233 | 204 | 10 | IPR011990 |
| Domain | P4Ha_N | 3.54e-04 | 3 | 204 | 2 | PF08336 | |
| Domain | Phosphoglycerate_kinase | 3.54e-04 | 3 | 204 | 2 | IPR001576 | |
| Domain | Pro_4_hyd_alph_N | 3.54e-04 | 3 | 204 | 2 | IPR013547 | |
| Domain | - | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 ANKRD34C | 4.13e-04 | 248 | 204 | 10 | 1.25.40.20 |
| Domain | ANK | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 ANKRD34C | 4.53e-04 | 251 | 204 | 10 | SM00248 |
| Domain | TPR_1 | 4.58e-04 | 90 | 204 | 6 | IPR001440 | |
| Domain | TPR_1 | 4.58e-04 | 90 | 204 | 6 | PF00515 | |
| Domain | - | 4.65e-04 | 207 | 204 | 9 | 1.25.40.10 | |
| Domain | ANK_REPEAT | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 ANKRD34C | 4.82e-04 | 253 | 204 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 ANKRD34C | 4.97e-04 | 254 | 204 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 ANKRD34C | 4.97e-04 | 254 | 204 | 10 | PS50297 |
| Domain | Myosin_N | 5.30e-04 | 15 | 204 | 3 | PF02736 | |
| Domain | Myosin_N | 5.30e-04 | 15 | 204 | 3 | IPR004009 | |
| Domain | Ank_2 | 6.12e-04 | 215 | 204 | 9 | PF12796 | |
| Domain | P4Hc | 6.47e-04 | 16 | 204 | 3 | SM00702 | |
| Domain | Pro_4_hyd_alph | 6.47e-04 | 16 | 204 | 3 | IPR006620 | |
| Domain | TPR_repeat | 6.52e-04 | 133 | 204 | 7 | IPR019734 | |
| Domain | Myotonic_dystrophy_kinase_coil | 7.02e-04 | 4 | 204 | 2 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 7.02e-04 | 4 | 204 | 2 | PD011252 | |
| Domain | DMPK_coil | 7.02e-04 | 4 | 204 | 2 | PF08826 | |
| Domain | LAM_G_DOMAIN | 7.63e-04 | 38 | 204 | 4 | PS50025 | |
| Domain | Myosin_tail_1 | 9.28e-04 | 18 | 204 | 3 | PF01576 | |
| Domain | Myosin_tail | 9.28e-04 | 18 | 204 | 3 | IPR002928 | |
| Domain | Laminin_G_2 | 9.28e-04 | 40 | 204 | 4 | PF02210 | |
| Domain | Myosin-like_IQ_dom | 1.09e-03 | 19 | 204 | 3 | IPR027401 | |
| Domain | - | 1.09e-03 | 19 | 204 | 3 | 4.10.270.10 | |
| Domain | ABC_transporter_CS | 1.12e-03 | 42 | 204 | 4 | IPR017871 | |
| Domain | Cadherin_C | 1.12e-03 | 42 | 204 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.12e-03 | 42 | 204 | 4 | PF16492 | |
| Domain | EGF | 1.15e-03 | 235 | 204 | 9 | SM00181 | |
| Domain | Ammonium_transpt | 1.16e-03 | 5 | 204 | 2 | IPR001905 | |
| Domain | Ammonium_transp | 1.16e-03 | 5 | 204 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 1.16e-03 | 5 | 204 | 2 | IPR024041 | |
| Domain | RhesusRHD | 1.16e-03 | 5 | 204 | 2 | IPR002229 | |
| Domain | LamG | 1.33e-03 | 44 | 204 | 4 | SM00282 | |
| Domain | FE2OG_OXY | 1.48e-03 | 21 | 204 | 3 | PS51471 | |
| Domain | HISTONE_H2A | 1.48e-03 | 21 | 204 | 3 | PS00046 | |
| Domain | EGF-like_dom | 1.71e-03 | 249 | 204 | 9 | IPR000742 | |
| Domain | - | 1.73e-03 | 6 | 204 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.73e-03 | 6 | 204 | 2 | IPR016071 | |
| Domain | ABC_tran | 1.85e-03 | 48 | 204 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.85e-03 | 48 | 204 | 4 | PS50893 | |
| Domain | Spectrin | 1.94e-03 | 23 | 204 | 3 | PF00435 | |
| Domain | Histone_H2A | 1.94e-03 | 23 | 204 | 3 | IPR002119 | |
| Domain | H2A | 1.94e-03 | 23 | 204 | 3 | SM00414 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 1.94e-03 | 23 | 204 | 3 | IPR005123 | |
| Domain | ABC_TRANSPORTER_1 | 1.99e-03 | 49 | 204 | 4 | PS00211 | |
| Domain | Prot_inhib_I29 | 2.40e-03 | 7 | 204 | 2 | IPR013201 | |
| Domain | Inhibitor_I29 | 2.40e-03 | 7 | 204 | 2 | PF08246 | |
| Domain | - | 2.40e-03 | 7 | 204 | 2 | 1.10.3430.10 | |
| Domain | Inhibitor_I29 | 2.40e-03 | 7 | 204 | 2 | SM00848 | |
| Domain | Ammonium/urea_transptr | 2.40e-03 | 7 | 204 | 2 | IPR029020 | |
| Domain | TPR | 2.95e-03 | 129 | 204 | 6 | SM00028 | |
| Domain | - | 3.11e-03 | 222 | 204 | 8 | 1.25.10.10 | |
| Domain | Histone_H5 | 3.18e-03 | 8 | 204 | 2 | IPR005819 | |
| Domain | BIR | 3.18e-03 | 8 | 204 | 2 | PF00653 | |
| Domain | BIR_REPEAT_2 | 3.18e-03 | 8 | 204 | 2 | PS50143 | |
| Domain | BIR | 3.18e-03 | 8 | 204 | 2 | SM00238 | |
| Domain | VIT | 3.18e-03 | 8 | 204 | 2 | PF08487 | |
| Domain | - | 3.18e-03 | 8 | 204 | 2 | 1.10.1170.10 | |
| Domain | VIT | 3.18e-03 | 8 | 204 | 2 | SM00609 | |
| Domain | LAMININ_IVA | 3.18e-03 | 8 | 204 | 2 | PS51115 | |
| Domain | Laminin_B | 3.18e-03 | 8 | 204 | 2 | PF00052 | |
| Domain | LamB | 3.18e-03 | 8 | 204 | 2 | SM00281 | |
| Domain | BIR_rpt | 3.18e-03 | 8 | 204 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 3.18e-03 | 8 | 204 | 2 | PS01282 | |
| Domain | Laminin_IV | 3.18e-03 | 8 | 204 | 2 | IPR000034 | |
| Domain | VWA | 3.26e-03 | 56 | 204 | 4 | PF00092 | |
| Domain | Ank | 3.66e-03 | 228 | 204 | 8 | PF00023 | |
| Domain | Laminin_G | 3.70e-03 | 58 | 204 | 4 | IPR001791 | |
| Domain | Spectrin_repeat | 3.81e-03 | 29 | 204 | 3 | IPR002017 | |
| Domain | - | 3.87e-03 | 95 | 204 | 5 | 2.60.120.200 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.63e-05 | 31 | 148 | 5 | M877 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 3.28e-05 | 86 | 148 | 7 | M39375 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.04e-05 | 121 | 148 | 8 | M872 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TRIO RPS5 SPTAN1 NFASC TUBA3E DSCAML1 SEMA6D SCN4B SEMA6A HSPA8 COL2A1 ANK2 ANK3 LAMA2 LAMC1 TIAM1 TLN1 | 1.12e-04 | 575 | 148 | 17 | M29853 |
| Pubmed | MYH2 MYH8 H2AZ2 MYH13 RPS5 ACO2 SPTAN1 EML6 PGK1 PGK2 TASOR2 ABCB1 ABCB4 ACSL3 NRXN3 PXDN SACS PDIA2 ITIH6 TASOR HSPA8 RGPD5 KRT13 ANK2 KRT17 RGPD8 KRT19 NELFCD SYNE1 ABCB5 RNF17 SF3B3 SLC25A12 SND1 SUSD1 H1-2 H1-4 H2AZ1 UGGT2 GABPA | 2.44e-16 | 1442 | 205 | 40 | 35575683 | |
| Pubmed | MYH2 MYH8 H2AZ2 RPS5 TUBA3E PGK1 ACSL3 HSPA8 RGPD5 RGPD8 ANK3 KRT19 ANXA1 SYNE1 FASTKD2 SF3B3 SND1 TLN1 H1-2 H1-4 H2AZ1 EIF3F PALLD | 1.32e-09 | 844 | 205 | 23 | 25963833 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | H2AZ2 ACLY PGK1 PGK2 ABCB1 ABCB4 FCGBP PXDN GRHPR PROM2 GNS HSPA8 KRT13 ITCH CILP FOLH1 ANXA1 SHMT1 LAMC1 VWA1 LIFR AKR7L TLN1 AKR7A3 H2AZ1 | 5.43e-09 | 1070 | 205 | 25 | 23533145 |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.74e-08 | 6 | 205 | 4 | 23728480 | |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 2.87e-08 | 197 | 205 | 11 | 29872149 | |
| Pubmed | SPTAN1 RRM1 ACSL3 SACS ZNF644 SEMA6A FKBP8 HSPA8 KRT13 ITCH ANK2 ANK3 MTHFD1L SYNE1 SHMT1 LAMC1 FASTKD2 CDC42BPB LIFR NBAS IARS2 SF3B3 TIAM1 SND1 TLN1 UGGT2 TTC17 NEURL4 | 6.24e-08 | 1487 | 205 | 28 | 33957083 | |
| Pubmed | H2AZ2 ACLY RPS5 ACO2 PGK1 CASKIN1 FKBP8 HSPA8 KRT17 ANXA1 MTHFD1L SYNE1 RIOX1 IARS2 SF3B3 SLC25A12 SND1 TLN1 H1-2 EIF3F | 7.28e-08 | 803 | 205 | 20 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | H2AZ2 ACLY ACO2 SPTAN1 PGK1 GRHPR HSPA8 COL2A1 ANK3 ANXA1 SYNE1 NBAS IARS2 SF3B3 SND1 TLN1 H1-2 H1-4 EIF3F NNT | 7.88e-08 | 807 | 205 | 20 | 30575818 |
| Pubmed | ATP6V0C TRIO ACLY RPS5 ACO2 SPTAN1 NFASC PGK1 SACS WASHC5 CASKIN1 HSPA8 ARMC8 ANK2 ANK3 KRT19 ANXA1 SYNE1 RBP3 SRCIN1 SPECC1L CDC42BPB OPHN1 SF3B3 SLC25A12 SND1 TLN1 | 1.06e-07 | 1431 | 205 | 27 | 37142655 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPS5 HMGCS1 RRM1 PGK1 ACSL3 FCGBP GRHPR WASHC5 GNS HSPA8 KRT13 ITCH ANXA1 MTHFD1L LAMC1 SH3PXD2B IARS2 IPO9 SF3B3 SND1 TLN1 H1-2 PRKAG1 H2AZ1 NNT PALLD | 1.59e-07 | 1367 | 205 | 26 | 32687490 |
| Pubmed | 2.02e-07 | 3 | 205 | 3 | 9542318 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | MYH13 RPS5 SPTAN1 PGK1 ACSL3 HSPA8 KRT13 KRT17 KRT19 MTHFD1L BIRC2 SF3B3 SND1 H1-2 H1-4 EIF3F | 2.45e-07 | 558 | 205 | 16 | 27591049 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.87e-07 | 74 | 205 | 7 | 10817752 | |
| Pubmed | ABCC4 ACLY RPS5 TUBA3E HMGCS1 RRM1 ACSL3 GRHPR FKBP8 HSPA8 NELFCD USP24 IARS2 IPO9 SLC25A12 TLN1 H1-2 H1-4 EIF3F NNT | 3.01e-07 | 878 | 205 | 20 | 37223481 | |
| Pubmed | 3.78e-07 | 77 | 205 | 7 | 10835267 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ATP6V0C KDM5C PEX1 TSC2 ABCB1 ITCH ADAMTS1 BIRC2 LAMC1 IARS2 IPO9 NEURL4 | 4.04e-07 | 313 | 205 | 12 | 38270169 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACLY RPS5 ACO2 SPTAN1 RRM1 PGK1 ACSL3 GRHPR WASHC5 SQSTM1 HSPA8 ITCH GNL3L ANXA1 MTHFD1L FASTKD2 IPO9 SF3B3 SLC25A12 SND1 TLN1 H1-2 EIF3F WDFY3 PALLD | 4.80e-07 | 1353 | 205 | 25 | 29467282 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 4.92e-07 | 80 | 205 | 7 | 10716726 | |
| Pubmed | The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping. | 5.59e-07 | 12 | 205 | 4 | 10495887 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 SQSTM1 NFRKB FKBP8 ARMC8 RGPD5 P4HA2 ITCH KRT17 ADAMTS1 KRT19 ANXA1 MTHFD1L XIAP RIOX1 IPO9 SND1 PRKAG1 UGGT2 EIF3F NEURL4 | 6.11e-07 | 1005 | 205 | 21 | 19615732 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | ACLY SPTAN1 PGK1 SQSTM1 HSPA8 KRT19 ANXA1 MTHFD1L SPECC1L SF3B3 SND1 | 6.36e-07 | 268 | 205 | 11 | 33024031 |
| Pubmed | DCHS2 CNKSR1 TRIO SPTAN1 TSC2 DSCAML1 PGK1 GRHPR SACS GPSM2 ARMC8 ITCH ANK2 ANK3 ADAMTS1 FOLH1 SYNE1 BIRC2 CDC42BPB MSTO1 TIAM1 TTC17 EIF3F WDFY3 | 6.86e-07 | 1285 | 205 | 24 | 35914814 | |
| Pubmed | 8.04e-07 | 4 | 205 | 3 | 14500733 | ||
| Pubmed | H2AZ2 TRIO ACLY RPS5 SPTAN1 RRM1 ACSL3 PXDN SQSTM1 GNS HSPA8 P4HA2 ITCH MTHFD1L USP24 LAMC1 FASTKD2 CDC42BPB SND1 H1-2 H1-4 UGGT2 TTC17 PALLD | 8.08e-07 | 1297 | 205 | 24 | 33545068 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.10e-06 | 57 | 205 | 6 | 32633719 | |
| Pubmed | TRIO ACO2 SPTAN1 HMGCS1 PGK1 ACSL3 WASHC5 SQSTM1 CASKIN1 FKBP8 HSPA8 ANK2 RGPD8 ANK3 ANXA1 USP24 SRCIN1 CDC42BPB AKR7L H1-2 H1-4 AKR7A3 | 1.20e-06 | 1139 | 205 | 22 | 36417873 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.22e-06 | 58 | 205 | 6 | 30377227 | |
| Pubmed | Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy Pathway. | 1.41e-06 | 33 | 205 | 5 | 29149599 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | ACLY RRM1 PGK1 ACSL3 FKBP8 KRT17 KRT19 ANXA1 SF3B3 SLC25A12 SND1 TLN1 NNT | 1.54e-06 | 422 | 205 | 13 | 27342126 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2AZ2 ACLY RPS5 TSC2 RRM1 ACSL3 SQSTM1 FKBP8 HSPA8 RGPD5 GNL3L RGPD8 MTHFD1L SHMT1 IARS2 SF3B3 SLC25A12 SND1 H1-2 H1-4 EXO1 H2AZ1 EIF3F | 1.68e-06 | 1257 | 205 | 23 | 37317656 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH2 MYH8 MYH13 ACLY SPTAN1 PGK1 ACSL3 PXDN FKBP8 HSPA8 ITCH ANXA1 SPECC1L IPO9 SLC25A12 EIF3F | 1.70e-06 | 647 | 205 | 16 | 26618866 |
| Pubmed | Glial ankyrins facilitate paranodal axoglial junction assembly. | 2.00e-06 | 5 | 205 | 3 | 25362471 | |
| Pubmed | 2.00e-06 | 5 | 205 | 3 | 34888534 | ||
| Pubmed | 2.00e-06 | 5 | 205 | 3 | 28636612 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 ABCC4 TRIO NFASC ANKMY1 GALNT18 TASOR2 PXDN PROM2 EXOC6B SEMA6A ANKRD12 ZNF704 ITCH GNL3L ANK3 FOLH1 AFF3 XIAP SRCIN1 CDC42BPB TTC21B PRKAG1 TTC17 TANGO2 | 2.68e-06 | 1489 | 205 | 25 | 28611215 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 3.15e-06 | 68 | 205 | 6 | 11230163 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | H2AZ2 ACLY RPS5 PGK1 ABCB1 ACSL3 SACS SQSTM1 FKBP8 KRT17 ANXA1 SYNE1 LAMC1 SPECC1L SF3B3 SND1 TLN1 H1-4 NNT NEURL4 | 3.18e-06 | 1024 | 205 | 20 | 24711643 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.48e-06 | 202 | 205 | 9 | 33005030 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.98e-06 | 6 | 205 | 3 | 10077619 | |
| Pubmed | H2AZ2 RPS5 SPTAN1 HMGCS1 RRM1 PGK1 GNS HSPA8 SYNE1 SF3B3 SND1 H1-2 H1-4 | 4.25e-06 | 463 | 205 | 13 | 34901782 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 4.41e-06 | 72 | 205 | 6 | 10380929 | |
| Pubmed | TRIO KDM5C SPTAN1 EML6 PXDN SACS LAMC1 CDC42BPB SH3PXD2B EYS TLN1 | 5.04e-06 | 332 | 205 | 11 | 37433992 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | TRIO SQSTM1 TASOR USP24 BIRC2 SPECC1L SLC25A12 PRKAG1 NEURL4 | 5.16e-06 | 212 | 205 | 9 | 33853758 |
| Pubmed | ACLY ACO2 SPTAN1 PGK1 HSPA8 ANK2 ANK3 XIAP SRCIN1 SLC25A12 H1-2 H1-4 | 5.55e-06 | 403 | 205 | 12 | 30562941 | |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 6.94e-06 | 7 | 205 | 3 | 7495297 | |
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 35210422 | ||
| Pubmed | 6.94e-06 | 7 | 205 | 3 | 21148564 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH2 ATP6V0C MYH8 MYH13 TRIO PEX1 DMPK HSPA8 ZDHHC18 ANXA1 AFF3 BIRC2 SND1 IKBKE TLN1 PRKAG1 EIF3F PALLD | 8.52e-06 | 910 | 205 | 18 | 36736316 |
| Pubmed | MYH8 TRIO HSPA8 ITCH ANK2 KRT17 SYNE1 LAMA2 LAMC1 CDC42BPB TLN1 PAX7 PALLD | 9.07e-06 | 497 | 205 | 13 | 23414517 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PALD1 ACO2 PEX1 TSC2 ACSL3 SQSTM1 ZNF644 MTX3 FKBP8 RGPD8 NELFCD MTHFD1L SYNE1 BIRC2 XIAP FASTKD2 NBAS IARS2 SLC25A12 SND1 H1-4 TTC17 NNT NEURL4 | 9.21e-06 | 1496 | 205 | 24 | 32877691 |
| Pubmed | 1.02e-05 | 175 | 205 | 8 | 28071719 | ||
| Pubmed | 1.11e-05 | 8 | 205 | 3 | 23640897 | ||
| Pubmed | RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription. | 1.16e-05 | 50 | 205 | 5 | 30413534 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIO ACLY RPS5 ACO2 SPTAN1 PGK1 ACSL3 SQSTM1 HSPA8 ARMC8 GNL3L MTHFD1L SYNE1 XIAP FASTKD2 IARS2 IPO9 SF3B3 SND1 TLN1 H1-2 H2AZ1 NNT | 1.30e-05 | 1425 | 205 | 23 | 30948266 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ACLY PEX1 TSC2 ACSL3 PXDN SQSTM1 MTX3 FKBP8 ITCH GNL3L ADAMTS1 USP24 CTDNEP1 IPO9 SLC25A12 SND1 TLN1 UGGT2 | 1.35e-05 | 942 | 205 | 18 | 31073040 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.46e-05 | 184 | 205 | 8 | 32908313 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H2AZ2 ACLY RPS5 ACO2 SPTAN1 PXDN SQSTM1 HSPA8 GNL3L ANXA1 SYNE1 RIOX1 SPECC1L SF3B3 SND1 H1-2 H1-4 H2AZ1 | 1.49e-05 | 949 | 205 | 18 | 36574265 |
| Pubmed | ATP6V0C ACLY ACO2 SPTAN1 HMGCS1 PGK1 GRHPR SQSTM1 HSPA8 P4HA2 ANXA1 LAMC1 IARS2 SLC25A12 SND1 ANKRD34C NNT | 1.52e-05 | 859 | 205 | 17 | 31536960 | |
| Pubmed | PALD1 MYH2 SPTAN1 TSC2 RRM1 ACSL3 PXDN SQSTM1 FKBP8 GNS ARMC8 GNL3L MTHFD1L LAMC1 SPECC1L LIFR NBAS IARS2 IPO9 SF3B3 SND1 TLN1 EIF3F | 1.54e-05 | 1440 | 205 | 23 | 30833792 | |
| Pubmed | 1.65e-05 | 9 | 205 | 3 | 23645681 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ZNF143 ACLY RPS5 ACO2 ACSL3 HSPA8 ZNF704 ADAMTS1 MTHFD1L LAMC1 FASTKD2 IARS2 SF3B3 SLC25A12 SND1 AKR7L VWA5A TLN1 H1-2 AKR7A3 H2AZ1 UGGT2 CSGALNACT1 | 1.73e-05 | 1451 | 205 | 23 | 30550785 |
| Pubmed | TRIO SPTAN1 NFASC TSC2 PGK1 CASKIN1 HSPA8 ARMC8 ITCH ANK2 RGPD8 ANK3 SYNE1 SPECC1L CDC42BPB SH3PXD2B WDFY3 NEURL4 | 1.81e-05 | 963 | 205 | 18 | 28671696 | |
| Pubmed | 1.86e-05 | 55 | 205 | 5 | 27997827 | ||
| Pubmed | Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy. | 2.15e-05 | 28 | 205 | 4 | 25179606 | |
| Pubmed | 2.21e-05 | 57 | 205 | 5 | 31862882 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.35e-05 | 10 | 205 | 3 | 22159418 | |
| Pubmed | Nucleosome adaptability conferred by sequence and structural variations in histone H2A-H2B dimers. | 2.35e-05 | 10 | 205 | 3 | 25731851 | |
| Pubmed | 2.48e-05 | 144 | 205 | 7 | 35681168 | ||
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.62e-05 | 59 | 205 | 5 | 23754746 | |
| Pubmed | NFASC FCGR2B PDIA2 GNS ANK2 PCDHA12 PCDHA10 PCDHA7 H1-4 PAX7 | 2.85e-05 | 329 | 205 | 10 | 17474147 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 3.22e-05 | 11 | 205 | 3 | 9655502 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 8188244 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 10488067 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 24873882 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 3.46e-05 | 2 | 205 | 2 | 21705081 | |
| Pubmed | DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. | 3.46e-05 | 2 | 205 | 2 | 17900276 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 3.46e-05 | 2 | 205 | 2 | 9196326 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 32697929 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 17975830 | ||
| Pubmed | Review: the molecular basis of the Rh blood group phenotypes. | 3.46e-05 | 2 | 205 | 2 | 15373666 | |
| Pubmed | Intron 4 of the RH Gene in Han Chinese, Tibetan, and Mongol Populations. | 3.46e-05 | 2 | 205 | 2 | 26579938 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 8898203 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 8441629 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 11161244 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 9284906 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 2473069 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 22738288 | ||
| Pubmed | Multiple Rh messenger RNA isoforms are produced by alternative splicing. | 3.46e-05 | 2 | 205 | 2 | 1379850 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 19185004 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 10329015 | ||
| Pubmed | PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. | 3.46e-05 | 2 | 205 | 2 | 22374423 | |
| Pubmed | PCDHA9 as a candidate gene for amyotrophic lateral sclerosis. | 3.46e-05 | 2 | 205 | 2 | 38467605 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 3135863 | ||
| Pubmed | Sequences and evolution of mammalian RH gene transcripts and proteins. | 3.46e-05 | 2 | 205 | 2 | 9811965 | |
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 8872477 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 12393640 | ||
| Pubmed | 3.46e-05 | 2 | 205 | 2 | 12851723 | ||
| Pubmed | Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy. | 3.46e-05 | 2 | 205 | 2 | 34081952 | |
| Pubmed | Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. | 3.46e-05 | 2 | 205 | 2 | 7916743 | |
| Interaction | CYLD interactions | MYH13 ACLY RPS5 SPTAN1 PGK1 ACSL3 PXDN SQSTM1 HSPA8 KRT13 ITCH TRPA1 KRT17 KRT19 MTHFD1L BIRC2 SF3B3 SND1 IKBKE TLN1 H1-2 H1-4 EIF3F PALLD | 7.51e-06 | 868 | 203 | 24 | int:CYLD |
| Interaction | PCDHB12 interactions | 9.24e-06 | 14 | 203 | 4 | int:PCDHB12 | |
| Cytoband | 5q31 | 9.31e-07 | 115 | 205 | 7 | 5q31 | |
| Cytoband | Xp11.22-p11.21 | 1.18e-04 | 4 | 205 | 2 | Xp11.22-p11.21 | |
| Cytoband | 1p36.11 | 2.51e-04 | 68 | 205 | 4 | 1p36.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.13e-04 | 298 | 205 | 7 | chr5q31 | |
| Cytoband | 17p13 | 4.74e-04 | 34 | 205 | 3 | 17p13 | |
| GeneFamily | Clustered protocadherins | 1.00e-05 | 64 | 140 | 6 | 20 | |
| GeneFamily | Ankyrin repeat domain containing | ANKMY1 CASKIN1 NFKBIB ANKRD12 TRPA1 ANK2 ANK3 ASPG ANKRD62 ANKRD34C | 1.92e-05 | 242 | 140 | 10 | 403 |
| GeneFamily | ATP binding cassette subfamily B | 7.16e-05 | 11 | 140 | 3 | 806 | |
| GeneFamily | Myosin heavy chains | 1.93e-04 | 15 | 140 | 3 | 1098 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.73e-04 | 115 | 140 | 6 | 769 | |
| GeneFamily | Keratins, type I | 1.29e-03 | 28 | 140 | 3 | 608 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.60e-03 | 161 | 140 | 6 | 593 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 1.62e-03 | 8 | 140 | 2 | 419 | |
| GeneFamily | Histones | 2.09e-03 | 116 | 140 | 5 | 864 | |
| GeneFamily | Laminin subunits | 3.73e-03 | 12 | 140 | 2 | 626 | |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | TRIO SPTAN1 RCBTB2 P4HA2 ADAMTS1 ST3GAL4 RGS2 LIFR SF3B3 H1-2 TTC17 PALLD | 4.95e-07 | 244 | 203 | 12 | M9945 |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_UP | KDM5C SPTAN1 DSCAML1 FCGR2B NFKBIB P4HA2 AMPD3 LAMA2 RGS2 PAX7 PALLD | 4.97e-07 | 200 | 203 | 11 | M3801 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CTSF H2AZ2 TRIO PEX1 NFASC DSCAML1 PCDH17 PXDN SEMA6D NFKBIB ANKRD12 FKBP8 TRIM2 ANK3 SYNE1 YIPF4 SRCIN1 NIPAL3 OPHN1 VWA5A H1-2 TANGO2 ULK2 | 1.63e-05 | 1102 | 203 | 23 | M2369 |
| Coexpression | NABA_MATRISOME | NRG1 CPAMD8 CTSF MATN1 P4HA3 PXDN SEMA6D SEMA6A ITIH6 COL2A1 P4HA2 CILP ADAMTS1 ANXA1 OGFOD2 LAMA2 LAMC1 VWA1 EYS VWA5A CTSW IL26 | 1.67e-05 | 1026 | 203 | 22 | M5889 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CTSF H2AZ2 TRIO PEX1 NFASC DSCAML1 PCDH17 PXDN SEMA6D NFKBIB ANKRD12 FKBP8 TRIM2 ANK3 SYNE1 YIPF4 SRCIN1 NIPAL3 OPHN1 VWA5A H1-2 TANGO2 ULK2 | 2.22e-05 | 1124 | 203 | 23 | MM1070 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | CTSF TRIO TSC2 PXDN SACS HPGDS NFRKB MED21 FKBP8 NBAS IKBKE FEV | 3.63e-05 | 372 | 203 | 12 | M19261 |
| Coexpression | NELSON_RESPONSE_TO_ANDROGEN_UP | 4.61e-05 | 83 | 203 | 6 | M13903 | |
| Coexpression | APPIERTO_RESPONSE_TO_FENRETINIDE_DN | 4.66e-05 | 51 | 203 | 5 | M14265 | |
| Coexpression | GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN | 4.76e-05 | 122 | 203 | 7 | M431 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 5.28e-05 | 124 | 203 | 7 | M7876 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-07 | 185 | 205 | 9 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.14e-07 | 186 | 205 | 9 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNT18 PCDH17 PXDN FCGR2B SEMA6A CYP26B1 ADAMTS1 LIFR UNC45B | 3.18e-07 | 195 | 205 | 9 | 126f46dd15dddcf5701144718bb8ba1ce84b2d1d |
| ToppCell | Mesenchymal_cells-Myofibroblasts|World / Lineage and Cell class | 3.32e-07 | 196 | 205 | 9 | 2c0f429ae18c2df05c33ddf58dcc2c94b819b9a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-06 | 169 | 205 | 8 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 177 | 205 | 8 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 177 | 205 | 8 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.02e-06 | 181 | 205 | 8 | 61608123959483ff60f07d8467996853c4371b6a | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.02e-06 | 181 | 205 | 8 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCC4 SPTAN1 FCGR2B SEMA6A PCDHB14 PCDHB11 UNC45B CSGALNACT1 | 2.02e-06 | 181 | 205 | 8 | 4df7972f88117108698efd06b124b232f8588981 |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCC4 SPTAN1 FCGR2B SEMA6A PCDHB14 PCDHB11 UNC45B CSGALNACT1 | 2.02e-06 | 181 | 205 | 8 | cbb530566893281289026bfd93adf721decd4ca3 |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 2.28e-06 | 184 | 205 | 8 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 186 | 205 | 8 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 2.47e-06 | 186 | 205 | 8 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 2.57e-06 | 187 | 205 | 8 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-06 | 187 | 205 | 8 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 188 | 205 | 8 | b651024d58ed1bcfe0d80b21755f8bf709eda81f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 188 | 205 | 8 | 51c6796a9488c056a10d048082015342c2e037f9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-06 | 188 | 205 | 8 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-06 | 189 | 205 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-06 | 189 | 205 | 8 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.78e-06 | 189 | 205 | 8 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.89e-06 | 190 | 205 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.01e-06 | 191 | 205 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-06 | 191 | 205 | 8 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 192 | 205 | 8 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 192 | 205 | 8 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 194 | 205 | 8 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 194 | 205 | 8 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 3.38e-06 | 194 | 205 | 8 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.51e-06 | 195 | 205 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.64e-06 | 196 | 205 | 8 | 74093f85e095606d1c723e0d7c2d78d9cfa47c4f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 196 | 205 | 8 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.64e-06 | 196 | 205 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-06 | 198 | 205 | 8 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.93e-06 | 198 | 205 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 198 | 205 | 8 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-06 | 198 | 205 | 8 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | (7)_Mast_cell|World / shred on Cell_type and subtype | 4.07e-06 | 199 | 205 | 8 | c0b5f1cb435da99a7e2ebac9ee7d7b1bd0e49b42 | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 4.23e-06 | 200 | 205 | 8 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 4.23e-06 | 200 | 205 | 8 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 4.23e-06 | 200 | 205 | 8 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 4.23e-06 | 200 | 205 | 8 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 4.23e-06 | 200 | 205 | 8 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | (70)_Mast|World / shred on Cell_type and subtype | 4.72e-06 | 203 | 205 | 8 | b7af2130b4965661b5a50717a7f82d8d498f8d08 | |
| ToppCell | Tuft-tuft-3|World / Class top | 5.71e-06 | 148 | 205 | 7 | f4f59b46a79fc9aa4c5d330a7b37b1a34a6d71cc | |
| ToppCell | Control-Myeloid-DC_Langerhans|Control / Disease state, Lineage and Cell class | 8.07e-06 | 156 | 205 | 7 | 58f371722d21005a9be2e67844ec2e5fec6e31e5 | |
| ToppCell | Control-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 8.77e-06 | 158 | 205 | 7 | ec425ec7b8e3c527b4bbe57908d84528b9747796 | |
| ToppCell | Control-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 9.52e-06 | 160 | 205 | 7 | 174775fb5cc7b478c6cd04f7c565738648ec2fc3 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 163 | 205 | 7 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 163 | 205 | 7 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 163 | 205 | 7 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 163 | 205 | 7 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 163 | 205 | 7 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-05 | 163 | 205 | 7 | be6cc44df9a2b10dce1a353717c279c3558f8fec | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.16e-05 | 165 | 205 | 7 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.16e-05 | 165 | 205 | 7 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 166 | 205 | 7 | c948df4279ff55b0d2739ad08b145c96ef2dbc97 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 1.47e-05 | 171 | 205 | 7 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-05 | 116 | 205 | 6 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.64e-05 | 174 | 205 | 7 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 174 | 205 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 69 | 205 | 5 | 3074ec10315fb21048215125ec08b0d7922da3d9 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 69 | 205 | 5 | f731d4500b139a8bef5c9185368509bf5a3791db | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 69 | 205 | 5 | 40eb84fe36da5a4a82bd9b2d962b829e2c97a059 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 205 | 7 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 205 | 7 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-05 | 179 | 205 | 7 | 878b15ea62e3405682a538f79f58d74b9cd3f398 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.97e-05 | 179 | 205 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.04e-05 | 180 | 205 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-05 | 180 | 205 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.12e-05 | 181 | 205 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.19e-05 | 182 | 205 | 7 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.19e-05 | 182 | 205 | 7 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.19e-05 | 182 | 205 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 182 | 205 | 7 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-05 | 183 | 205 | 7 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.35e-05 | 184 | 205 | 7 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 2.35e-05 | 184 | 205 | 7 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-05 | 185 | 205 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 185 | 205 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 186 | 205 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.52e-05 | 186 | 205 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 186 | 205 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 186 | 205 | 7 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.52e-05 | 186 | 205 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.61e-05 | 187 | 205 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 187 | 205 | 7 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 187 | 205 | 7 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 187 | 205 | 7 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-05 | 188 | 205 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 2.70e-05 | 188 | 205 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 2.70e-05 | 188 | 205 | 7 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 2.70e-05 | 188 | 205 | 7 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-05 | 188 | 205 | 7 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.79e-05 | 189 | 205 | 7 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 189 | 205 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| Drug | tXMP | 4.18e-07 | 8 | 203 | 4 | CID003081384 | |
| Drug | So324 | 7.46e-07 | 9 | 203 | 4 | CID000462261 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | ABCC4 CTSF ANKMY1 SACS KRT13 ITCH TRIM2 CYP26B1 ST3GAL4 RGS2 | 4.72e-06 | 178 | 203 | 10 | 1636_UP |
| Drug | AC1L2MCS | 6.89e-06 | 5 | 203 | 3 | CID000023441 | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.21e-05 | 198 | 203 | 10 | 6681_DN | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.21e-05 | 157 | 203 | 9 | 2651_UP | |
| Drug | AC1L99H3 | 1.37e-05 | 6 | 203 | 3 | CID000440540 | |
| Drug | v 104 | 1.37e-05 | 6 | 203 | 3 | CID000107262 | |
| Drug | thioinosine | 1.40e-05 | 35 | 203 | 5 | CID000676166 | |
| Drug | NBD-Cl | 2.12e-05 | 38 | 203 | 5 | CID000025043 | |
| Drug | Graphite | 2.12e-05 | 38 | 203 | 5 | ctd:D006108 | |
| Drug | moxidectin | 2.14e-05 | 19 | 203 | 4 | CID009571036 | |
| Drug | arsenic trioxide | ABCC4 H2AZ2 RCBTB2 ABCB1 PXDN ANKRD12 ANK3 ABCB5 BIRC2 LAMC1 XIAP RGS2 H1-2 H1-4 H2AZ1 | 2.14e-05 | 468 | 203 | 15 | CID000014888 |
| Drug | celastrol; Up 200; 2.5uM; MCF7; HT_HG-U133A_EA | 2.39e-05 | 171 | 203 | 9 | 887_UP | |
| Drug | O746 | 2.66e-05 | 20 | 203 | 4 | CID006327063 | |
| Drug | beta-NADP | ACLY ACO2 HMGCS1 RRM1 PGK1 PGK2 GRHPR CYP26B1 ADAMTS1 ASPG MTHFD1L SHMT1 EYS AKR7L NNT | 3.64e-05 | 490 | 203 | 15 | CID000000929 |
| Drug | molybdenum | 3.74e-05 | 181 | 203 | 9 | CID000023932 | |
| Drug | Cm-pc | 3.78e-05 | 8 | 203 | 3 | CID000196491 | |
| Drug | cinchonan-9-ol | 3.78e-05 | 8 | 203 | 3 | CID000002757 | |
| Drug | tBCEU | 3.78e-05 | 8 | 203 | 3 | CID000164059 | |
| Drug | nicotine glucuronide | 3.78e-05 | 8 | 203 | 3 | CID003035848 | |
| Drug | iodoarylazidoprazosin | 3.78e-05 | 8 | 203 | 3 | CID000115344 | |
| Drug | beryllium fluoride | 3.88e-05 | 103 | 203 | 7 | CID000024589 | |
| Drug | AC1NQAAM | 4.65e-05 | 144 | 203 | 8 | CID005192834 | |
| Drug | thioinosinic acid | 4.76e-05 | 23 | 203 | 4 | CID003034391 | |
| Drug | procainamide | 5.45e-05 | 190 | 203 | 9 | CID000004913 | |
| Drug | AC1N9ZZC | 5.92e-05 | 149 | 203 | 8 | CID004369374 | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.41e-05 | 194 | 203 | 9 | 3932_DN | |
| Drug | NU1025; Up 200; 100uM; MCF7; HG-U133A | 6.41e-05 | 194 | 203 | 9 | 608_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.66e-05 | 195 | 203 | 9 | 4466_DN | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; HL60; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 6131_UP | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 7.21e-05 | 197 | 203 | 9 | 5302_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 7.50e-05 | 198 | 203 | 9 | 2492_UP | |
| Drug | LEO275 | 7.55e-05 | 79 | 203 | 6 | CID000018140 | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 7.79e-05 | 199 | 203 | 9 | 6214_DN | |
| Drug | mesochlorin e6 monoethylenediamine | 7.91e-05 | 2 | 203 | 2 | CID005488855 | |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 7.91e-05 | 2 | 203 | 2 | CID000135804 | |
| Drug | taxuspine C | 7.91e-05 | 2 | 203 | 2 | CID005321745 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 7.91e-05 | 2 | 203 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 7.91e-05 | 2 | 203 | 2 | CID000197370 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 7.91e-05 | 2 | 203 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 7.91e-05 | 2 | 203 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 7.91e-05 | 2 | 203 | 2 | CID000155836 | |
| Drug | 1,9-dideoxyforskolin | 7.91e-05 | 2 | 203 | 2 | ctd:C047983 | |
| Drug | DAPDOX | 7.91e-05 | 2 | 203 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 7.91e-05 | 2 | 203 | 2 | CID000164322 | |
| Drug | YM212 | 7.91e-05 | 2 | 203 | 2 | CID000129980 | |
| Drug | sikkimotoxin | 7.91e-05 | 2 | 203 | 2 | CID003010626 | |
| Drug | surugatoxin | 7.91e-05 | 2 | 203 | 2 | CID003034617 | |
| Drug | Ro11-2933 | 7.91e-05 | 2 | 203 | 2 | CID000115215 | |
| Drug | cnidiadin | 7.91e-05 | 2 | 203 | 2 | CID005315980 | |
| Drug | conferone | 7.91e-05 | 2 | 203 | 2 | CID001757335 | |
| Drug | NSC330500 | 7.91e-05 | 2 | 203 | 2 | CID000433448 | |
| Drug | VX-710-3 | 7.91e-05 | 2 | 203 | 2 | CID006450549 | |
| Drug | NAc-LLY-amide | 7.91e-05 | 2 | 203 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 7.91e-05 | 2 | 203 | 2 | CID006449905 | |
| Drug | NSC4586 | 7.91e-05 | 2 | 203 | 2 | CID000072506 | |
| Drug | AC1MZ4R5 | 8.00e-05 | 10 | 203 | 3 | CID003842392 | |
| Drug | Emd 51921 | 8.00e-05 | 10 | 203 | 3 | CID000164353 | |
| Drug | diC4PC | 8.00e-05 | 10 | 203 | 3 | CID000193375 | |
| Drug | NSC91998 | 8.69e-05 | 81 | 203 | 6 | CID000005668 | |
| Drug | Docetaxel trihydrate | 8.74e-05 | 202 | 203 | 9 | CID000003143 | |
| Drug | atazanavir | 1.03e-04 | 120 | 203 | 7 | CID000148192 | |
| Drug | oxovanadium | 1.03e-04 | 120 | 203 | 7 | CID000024411 | |
| Drug | CKI-7 | 1.09e-04 | 53 | 203 | 5 | CID000129236 | |
| Drug | dithiane | 1.09e-04 | 11 | 203 | 3 | CID000136335 | |
| Drug | AC1L1G85 | 1.19e-04 | 54 | 203 | 5 | CID000003569 | |
| Drug | butane | 1.20e-04 | 123 | 203 | 7 | CID000007843 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 1.22e-04 | 29 | 203 | 4 | CID000006747 | |
| Drug | AC1L9E0Q | 1.40e-04 | 30 | 203 | 4 | CID000443095 | |
| Drug | IC-1 | 1.45e-04 | 12 | 203 | 3 | CID000049829 | |
| Drug | Ant-dATP | 1.45e-04 | 12 | 203 | 3 | CID000131323 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.81e-04 | 175 | 203 | 8 | 5222_UP | |
| Drug | AC1L1AUV | 1.87e-04 | 13 | 203 | 3 | CID000051323 | |
| Drug | 5-carboxyfluorescein diacetate | 1.87e-04 | 13 | 203 | 3 | CID000133314 | |
| Drug | UCF 101 | 1.87e-04 | 13 | 203 | 3 | ctd:C501517 | |
| Drug | I mAb | 1.87e-04 | 13 | 203 | 3 | CID003082777 | |
| Drug | Therarubicin | 1.97e-04 | 60 | 203 | 5 | CID000004844 | |
| Drug | indole-3-carbinol | NRG1 MYH2 ABCC4 CCDC88B ABCB1 ACSL3 SACS HPGDS SCN4B MED21 KRT19 ASPG AMDHD1 BIRC2 XIAP USH1C RGS2 SUSD1 IKBKE UNC45B AKR7A3 TANGO2 CDH17 | 1.98e-04 | 1130 | 203 | 23 | ctd:C016517 |
| Drug | triadimefon | ABCC4 HMGCS1 ABCB1 ABCB4 ACSL3 SEMA6D HSPA8 CYP26B1 KRT19 ANXA1 IKBKE AKR7A3 | 2.06e-04 | 389 | 203 | 12 | ctd:C032910 |
| Drug | 6-methylpurine-2'-deoxyriboside | 2.13e-04 | 61 | 203 | 5 | CID000097184 | |
| Drug | Calcein AM | 2.30e-04 | 62 | 203 | 5 | CID000390986 | |
| Drug | AC1L8YYB | 2.31e-04 | 34 | 203 | 4 | CID000435167 | |
| Drug | amentoflavone | 2.31e-04 | 34 | 203 | 4 | CID005281600 | |
| Drug | 2-chloroquinazoline | 2.36e-04 | 3 | 203 | 2 | CID000074054 | |
| Drug | fluoroanilinoazatoxin | 2.36e-04 | 3 | 203 | 2 | CID000378896 | |
| Drug | Dihydrocyclosporin C | 2.36e-04 | 3 | 203 | 2 | CID000196411 | |
| Drug | NSC82591 | 2.36e-04 | 3 | 203 | 2 | CID000579054 | |
| Drug | CID5317124 | 2.36e-04 | 3 | 203 | 2 | CID005317124 | |
| Drug | NSC688503 | 2.36e-04 | 3 | 203 | 2 | CID000390744 | |
| Drug | Cp-100356 | 2.36e-04 | 3 | 203 | 2 | CID000196918 | |
| Drug | BIBW22BS | 2.36e-04 | 3 | 203 | 2 | CID000132088 | |
| Drug | AC1NSGRQ | 2.36e-04 | 3 | 203 | 2 | CID005333904 | |
| Drug | AC1O5U9L | 2.36e-04 | 3 | 203 | 2 | CID006440811 | |
| Drug | Technetium Tc 99m Sestamibi | 2.36e-04 | 3 | 203 | 2 | ctd:D017256 | |
| Drug | taxinine | 2.36e-04 | 3 | 203 | 2 | CID005321702 | |
| Drug | Hapalosin | 2.36e-04 | 3 | 203 | 2 | CID000133055 | |
| Drug | haemanthidine | 2.36e-04 | 3 | 203 | 2 | CID000124066 | |
| Drug | taccalonolide A | 2.36e-04 | 3 | 203 | 2 | CID000441685 | |
| Drug | taccalonolide E | 2.36e-04 | 3 | 203 | 2 | CID005321583 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 2.32e-07 | 9 | 196 | 4 | DOID:1485 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 8.96e-07 | 12 | 196 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | myopia (is_implicated_in) | 3.23e-06 | 16 | 196 | 4 | DOID:11830 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | CPAMD8 ABCC4 DSCAML1 ABCB1 ABCB4 SACS ANK2 FOLH1 MTHFD1L SYNE1 ABCB5 RBP3 LAMC1 LIFR TIAM1 H1-4 EXO1 | 5.09e-06 | 702 | 196 | 17 | C0009402 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.35e-05 | 10 | 196 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 4.23e-05 | 95 | 196 | 6 | C0279626 | |
| Disease | Anemia, Hemolytic, Congenital | 4.39e-05 | 2 | 196 | 2 | C0002881 | |
| Disease | Cholelithiasis | 4.39e-05 | 2 | 196 | 2 | C0008350 | |
| Disease | distal myopathy (implicated_via_orthology) | 6.08e-05 | 12 | 196 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | venous thromboembolism | DCHS2 MYH8 ITCH ANK2 ANK3 FOLH1 TOGARAM2 ST3GAL4 FASTKD2 SUSD1 H1-2 CSGALNACT1 | 6.43e-05 | 460 | 196 | 12 | EFO_0004286 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.36e-05 | 152 | 196 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | xanthine measurement | 7.86e-05 | 13 | 196 | 3 | EFO_0010548 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.86e-05 | 13 | 196 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | retinal detachment, retinal break | 8.41e-05 | 35 | 196 | 4 | EFO_0005773, EFO_0010698 | |
| Disease | Drug habituation | 1.23e-04 | 115 | 196 | 6 | C0013170 | |
| Disease | Drug abuse | 1.23e-04 | 115 | 196 | 6 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.23e-04 | 115 | 196 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 1.23e-04 | 115 | 196 | 6 | C0236969 | |
| Disease | Drug Use Disorders | 1.23e-04 | 115 | 196 | 6 | C0013222 | |
| Disease | Drug Dependence | 1.23e-04 | 115 | 196 | 6 | C1510472 | |
| Disease | Substance Dependence | 1.23e-04 | 115 | 196 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 1.23e-04 | 115 | 196 | 6 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.23e-04 | 115 | 196 | 6 | C0029231 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.24e-04 | 15 | 196 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Substance abuse problem | 1.29e-04 | 116 | 196 | 6 | C0740858 | |
| Disease | RHABDOMYOSARCOMA 2 | 1.31e-04 | 3 | 196 | 2 | 268220 | |
| Disease | Rh Deficiency Syndrome | 1.31e-04 | 3 | 196 | 2 | C0272052 | |
| Disease | alveolar rhabdomyosarcoma (is_implicated_in) | 1.31e-04 | 3 | 196 | 2 | DOID:4051 (is_implicated_in) | |
| Disease | Rh-Null, Regulator Type | 1.31e-04 | 3 | 196 | 2 | C1849387 | |
| Disease | Alveolar rhabdomyosarcoma | 1.31e-04 | 3 | 196 | 2 | cv:C0206655 | |
| Disease | Abnormality of refraction | CHDH PKD1L1 DSCAML1 GALNT18 TSHZ3 ANK3 MTHFD1L FAT3 LAMA2 PCDHA12 PCDHA10 PCDHA7 ST3GAL4 SLC25A12 | 1.76e-04 | 673 | 196 | 14 | HP_0000539 |
| Disease | Acute Myeloid Leukemia, M1 | 1.94e-04 | 125 | 196 | 6 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.94e-04 | 125 | 196 | 6 | C1879321 | |
| Disease | intrahepatic cholestasis (implicated_via_orthology) | 2.61e-04 | 4 | 196 | 2 | DOID:1852 (implicated_via_orthology) | |
| Disease | Macrostomia | 2.61e-04 | 4 | 196 | 2 | C0024433 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.61e-04 | 4 | 196 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NRG1 ACO2 SPTAN1 ABCB1 ZNF644 ANK2 ADAMTS1 SYNE1 LAMA2 SHMT1 BIRC2 SIM1 RGS2 RHD UNC45B H1-2 SLC28A1 EXO1 | 3.14e-04 | 1074 | 196 | 18 | C0006142 |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.51e-04 | 21 | 196 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | episodic memory | 3.98e-04 | 52 | 196 | 4 | EFO_0004333 | |
| Disease | Alveolar rhabdomyosarcoma | 4.33e-04 | 5 | 196 | 2 | C0206655 | |
| Disease | Anterior segment mesenchymal dysgenesis | 4.33e-04 | 5 | 196 | 2 | C1862839 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 4.33e-04 | 5 | 196 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 H2AZ2 NKX2-3 TSC2 RRM1 FCGR2B PDIA2 ANKRD12 FKBP8 HSPA8 FOXO1 CYP26B1 RHCE RHD SUSD1 H1-2 EXO1 EIF3F | 4.40e-04 | 1105 | 196 | 18 | EFO_0004528 |
| Disease | Mouth Neoplasms | 4.61e-04 | 54 | 196 | 4 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 4.61e-04 | 54 | 196 | 4 | C0153381 | |
| Disease | unipolar depression, bipolar disorder, mental or behavioural disorder | 6.47e-04 | 6 | 196 | 2 | EFO_0000677, EFO_0003761, MONDO_0004985 | |
| Disease | Mammary Carcinoma, Human | NRG1 ABCB1 ADAMTS1 SYNE1 SHMT1 BIRC2 SIM1 RGS2 H1-2 SLC28A1 EXO1 | 8.23e-04 | 525 | 196 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | NRG1 ABCB1 ADAMTS1 SYNE1 SHMT1 BIRC2 SIM1 RGS2 H1-2 SLC28A1 EXO1 | 8.23e-04 | 525 | 196 | 11 | C1257931 |
| Disease | stimulant use measurement | 8.37e-04 | 28 | 196 | 3 | EFO_0600076 | |
| Disease | Mammary Neoplasms | NRG1 ABCB1 ADAMTS1 SYNE1 SHMT1 BIRC2 SIM1 RGS2 H1-2 SLC28A1 EXO1 | 8.49e-04 | 527 | 196 | 11 | C1458155 |
| Disease | Vomiting | 9.02e-04 | 7 | 196 | 2 | C0042963 | |
| Disease | Cholangitis | 9.02e-04 | 7 | 196 | 2 | C0008311 | |
| Disease | 1,5 anhydroglucitol measurement | 9.29e-04 | 29 | 196 | 3 | EFO_0008009 | |
| Disease | bipolar disorder (is_implicated_in) | 9.29e-04 | 29 | 196 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | Breast Carcinoma | NRG1 ABCB1 ADAMTS1 SYNE1 SHMT1 BIRC2 SIM1 RGS2 H1-2 SLC28A1 EXO1 | 1.00e-03 | 538 | 196 | 11 | C0678222 |
| Disease | Leukemia, Myelocytic, Acute | 1.08e-03 | 173 | 196 | 6 | C0023467 | |
| Disease | postherpetic neuralgia | 1.20e-03 | 8 | 196 | 2 | MONDO_0041052 | |
| Disease | Anterior segment dysgenesis | 1.20e-03 | 8 | 196 | 2 | cv:C1862839 | |
| Disease | angiotensin-converting enzyme measurement | 1.53e-03 | 9 | 196 | 2 | EFO_0006515 | |
| Disease | gallbladder neoplasm | 1.53e-03 | 9 | 196 | 2 | EFO_0004606 | |
| Disease | underweight body mass index status | 1.53e-03 | 9 | 196 | 2 | EFO_0005936 | |
| Disease | behavioural disinhibition measurement | 1.59e-03 | 75 | 196 | 4 | EFO_0006946 | |
| Disease | medulloblastoma (is_implicated_in) | 1.91e-03 | 10 | 196 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | Liver carcinoma | 2.19e-03 | 507 | 196 | 10 | C2239176 | |
| Disease | Retinal Detachment | 2.32e-03 | 11 | 196 | 2 | C0035305 | |
| Disease | psychosocial stress measurement | 2.32e-03 | 11 | 196 | 2 | EFO_0006783 | |
| Disease | Kidney Neoplasm | 2.38e-03 | 40 | 196 | 3 | C0022665 | |
| Disease | Schizophrenia | NRG1 NFASC PCDH17 ABCB1 NRXN3 HPGDS ANK3 FOLH1 LAMA2 SHMT1 RGS2 RHD LIFR H1-4 | 2.44e-03 | 883 | 196 | 14 | C0036341 |
| Disease | Autism Spectrum Disorders | 2.51e-03 | 85 | 196 | 4 | C1510586 | |
| Disease | retinal vasculature measurement | 2.52e-03 | 517 | 196 | 10 | EFO_0010554 | |
| Disease | Colorectal Neoplasms | 2.62e-03 | 277 | 196 | 7 | C0009404 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.73e-03 | 87 | 196 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | Autoimmune Diseases | 2.74e-03 | 42 | 196 | 3 | C0004364 | |
| Disease | Parkinson Disease, Secondary Vascular | 2.77e-03 | 12 | 196 | 2 | C0751414 | |
| Disease | Atherosclerotic Parkinsonism | 2.77e-03 | 12 | 196 | 2 | C0751415 | |
| Disease | Secondary Parkinson Disease | 2.77e-03 | 12 | 196 | 2 | C0030569 | |
| Disease | emphysema imaging measurement | 2.98e-03 | 146 | 196 | 5 | EFO_0007626 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.09e-03 | 90 | 196 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | ventricular enlargement measurement | 3.26e-03 | 13 | 196 | 2 | EFO_0010570 | |
| Disease | Fetal Alcohol Spectrum Disorders | 3.26e-03 | 13 | 196 | 2 | C2985290 | |
| Disease | Malignant neoplasm of kidney | 3.34e-03 | 45 | 196 | 3 | C0740457 | |
| Disease | Neurodevelopmental Disorders | 3.48e-03 | 93 | 196 | 4 | C1535926 | |
| Disease | oropharynx cancer | 3.55e-03 | 46 | 196 | 3 | EFO_1001931 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 3.55e-03 | 46 | 196 | 3 | EFO_0005325, HP_0012735 | |
| Disease | myopathy (implicated_via_orthology) | 4.01e-03 | 48 | 196 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 4.25e-03 | 49 | 196 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | schizophrenia (biomarker_via_orthology) | 4.35e-03 | 15 | 196 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | Myopia | 4.35e-03 | 15 | 196 | 2 | C0027092 | |
| Disease | serum metabolite measurement | ABCC4 TRIO PKD1L1 PGK2 ABCB4 EXOC6B HSPA8 CYP26B1 TRPA1 NELFCD FOLH1 ASPG SLCO6A1 SLC28A1 | 4.44e-03 | 945 | 196 | 14 | EFO_0005653 |
| Disease | biological sex | 4.49e-03 | 230 | 196 | 6 | PATO_0000047 | |
| Disease | Psychotic Disorders | 4.67e-03 | 101 | 196 | 4 | C0033975 | |
| Disease | epilepsy (implicated_via_orthology) | 4.75e-03 | 163 | 196 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.95e-03 | 16 | 196 | 2 | DOID:0050888 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TDYTLAEAEAALQKA | 511 | Q9Y6N9 | |
| VKYLSGDIEAAFNNL | 501 | Q7Z4L5 | |
| ALTYFAQADALKGTL | 291 | Q5FVE4 | |
| YLSKTGREDIANLAD | 306 | Q99798 | |
| EKFGKALNYAEAALS | 996 | P51826 | |
| KSLEELQIGTYANIA | 191 | P54619 | |
| ALVEKALQAAYGASA | 246 | Q8NHP1 | |
| ALVEKALQAAYGASA | 246 | O95154 | |
| SALVYAINADDKDAL | 121 | P0C6C1 | |
| EAQALSGQAKRAELY | 301 | A6NC98 | |
| AEVNAGVKLATEYAA | 131 | Q8TDX6 | |
| KQAVTLGQDLAAYTT | 561 | Q9NQ94 | |
| LSAYSKAGAVAEEVL | 236 | Q2M3G0 | |
| AAAAAQDGALYKLPA | 151 | Q99581 | |
| EYLTAKVLELAGNEA | 61 | P0C5Z0 | |
| YLTAEVLELAGNASK | 61 | Q71UI9 | |
| LAAAGYDVEKNNSRI | 66 | P16403 | |
| ADKVGAENTITYSLL | 281 | P31994 | |
| KLLAYGADIEARSQD | 156 | A6NC57 | |
| AALAATLEEYKATVA | 556 | Q69YQ0 | |
| AGASELQSYLEELKG | 61 | Q96LT6 | |
| YDVAKILIAAGADVN | 231 | Q6UB98 | |
| TIAQAVYGAKDIELS | 871 | Q6UB35 | |
| AYASKEVILSGGAIN | 286 | Q8NE62 | |
| AGITLEDYEQAAKSL | 141 | Q01432 | |
| SIAYLDEAAGNLKKA | 1396 | P02458 | |
| VDGKLSIQCYLSALD | 216 | Q01581 | |
| RASLSKLGDVYVNDA | 151 | P07205 | |
| NAIALLSAAVKYDAQ | 491 | O95199 | |
| DVDADSGLLYTKQRI | 76 | O14917 | |
| TFANKIGQSALYDAL | 376 | Q99666 | |
| TFANKIGQSALYDAL | 376 | O14715 | |
| SFLAIKAADGTYILN | 766 | Q9UHI8 | |
| SAAKSDNLDYRLGAI | 471 | O60890 | |
| ELRINKASLADSGEY | 96 | Q02297 | |
| SLEASENIRALKDGY | 106 | Q7Z4N8 | |
| SAKALGSILAYLTDA | 521 | Q9ULE6 | |
| GQTAVDYLAKNVSLS | 466 | P23759 | |
| AYAKAGAVAEEVLAA | 246 | P08183 | |
| KDSTGLVNYLTDDLN | 1631 | Q01484 | |
| ISLCQAILDETKGDY | 321 | P04083 | |
| DADAQKNALVSYSLV | 481 | Q9UN72 | |
| AKQGADTLAYIALLE | 86 | Q5HYI7 | |
| YDLTSLNVKAGDIIT | 296 | Q8WXD9 | |
| YDNAELTLNVALGKV | 236 | Q6N063 | |
| LASYLDKVRALEAAN | 91 | P08727 | |
| TSNLINEASDYLEGK | 36 | A4D1F6 | |
| ASFSYKENLIGALLA | 26 | Q6P499 | |
| EDLKTLSAIYSQLGN | 56 | P81274 | |
| DVSDKLAQVGLVQYS | 306 | P21941 | |
| GYLDLDGINVTEKAS | 2816 | Q5T1H1 | |
| VNAGRKGSLAALYDL | 291 | Q6P4R8 | |
| NKGASELVAELSTLY | 401 | Q8IXH7 | |
| TSEAALAKLSYVLGQ | 326 | Q86U10 | |
| CDLKTLIGYSAAELN | 401 | Q06546 | |
| DEAINNVTLALKTYG | 301 | Q5FYB0 | |
| VTLENLTADDAGKYR | 96 | A0A0K2S4Q6 | |
| LKDGTLELIFAAYAT | 286 | Q9NR63 | |
| NAQLAGAKGVILYSD | 216 | Q04609 | |
| AIARYLTKNTDLAGN | 66 | O60760 | |
| VDLQADYNTAKGVLG | 406 | Q14164 | |
| EIATYRSLLEGQDAK | 401 | P13646 | |
| AAILGETSTVEKLYA | 101 | Q15653 | |
| TEVADKAAYLQSLNS | 381 | P13535 | |
| VGAKAAELLQDEYSG | 241 | Q9BUK6 | |
| TEVADKAAYLQSLNS | 381 | Q9UKX2 | |
| KSADYVNLALKDGAV | 301 | Q9Y4C0 | |
| STAALQAASLYKLEE | 81 | Q13503 | |
| TAVADNLLFYLGSAK | 2176 | P24043 | |
| TGDLGNKASDYLVDL | 631 | Q9Y2D4 | |
| YITSKINLVDLAGSE | 236 | Q9HAQ2 | |
| ALAPEYSKAAAVLAA | 76 | Q13087 | |
| RASLSKLGDVYVNDA | 151 | P00558 | |
| LFAASGAISYAEVLK | 276 | Q86UU5 | |
| SDEKDARGYLQALAS | 826 | Q9Y5S2 | |
| TADDQYKRETILGLA | 1661 | A2RRP1 | |
| LGASELAQDKYVADF | 36 | Q09013 | |
| SAKDLDVGINAVKSY | 156 | Q9Y5F1 | |
| LAAYAKAGAVAEEAL | 246 | P21439 | |
| EALTSKSAADAEGYL | 66 | O15460 | |
| VKSYNLSLSEDALVG | 2551 | Q6V1P9 | |
| ASDADVGENALLTYK | 156 | Q9Y5I2 | |
| SAKDLDVGINAVKSY | 156 | Q9Y5F2 | |
| SRYAALSDQGLDIKA | 1346 | Q8WX93 | |
| AKTLDAGQVGLALSY | 971 | O15439 | |
| GTAALDIYETLKSNN | 96 | Q96J02 | |
| DLAKAYLTVLADQAT | 601 | O94856 | |
| IATISAKDLDAGNYG | 261 | Q9Y5E9 | |
| AFKLYASLGANDEDI | 361 | Q8IUR7 | |
| DFVLAANSYDLAIKA | 236 | Q14318 | |
| GNLSYADLITKAIES | 161 | Q12778 | |
| KASLEGNLAETENRY | 321 | Q04695 | |
| VLQYAEDVLSGKVSA | 286 | O00303 | |
| GLYISDVQKEDALST | 181 | Q8TD84 | |
| SKALLVADFGLQVSY | 4181 | Q9Y6R7 | |
| LGLNNITAKALAYGD | 881 | Q8IZJ3 | |
| QDDLYQALASGKIAA | 251 | Q9UBQ7 | |
| AGSYDILTIKAVDNG | 1321 | Q8TDW7 | |
| GTLSQAVDALYIKAA | 36 | Q9NPH9 | |
| DIIAYGVLQNSLKTD | 466 | Q6P9A2 | |
| AYSAIKNLGGLETED | 341 | Q9UBX1 | |
| ITVLNNSGLASEKDY | 201 | P56202 | |
| IATTLLEYGADANAV | 646 | Q12955 | |
| ADVADAKGYTVLAAA | 286 | Q9P2S6 | |
| EALAAATINAAYALG | 361 | Q96NU7 | |
| DVLANVSLDFLDYKS | 206 | P15586 | |
| TDAALQLKGLYEEIS | 456 | Q6UXX5 | |
| AGQLLSDILATSKYE | 966 | Q96P70 | |
| LAAAGYDVEKNNSRI | 66 | P10412 | |
| YLTAEVLELAGNASK | 61 | P0C0S5 | |
| LDAAGNLTKISYVAD | 1526 | Q9ULL0 | |
| GDKAVEIYASVAQLS | 1261 | P11047 | |
| AKEDITYSGALNGDI | 206 | Q6ZMW3 | |
| VLAAEALTTAKGYVA | 256 | A6NKP2 | |
| KSDYGNLTLAEDTNI | 451 | Q12864 | |
| AKAALLELTGAVDYA | 61 | Q8ND90 | |
| EIDKSTGALNVLYSV | 2751 | Q9NZJ4 | |
| RVDESALAAQAYALK | 416 | Q8TC92 | |
| EGEKLSYLNSLAAAD | 66 | Q8TAU0 | |
| SFTGADLKALLYNAQ | 1041 | O43933 | |
| SQKDASVGYLSLLDA | 1651 | Q8TDX9 | |
| FSVLIGSDIADKLYA | 231 | Q9HBV1 | |
| GSDIADKLYALNDRV | 236 | Q9HBV1 | |
| SLQYAGAETLASKVQ | 1481 | Q96JN8 | |
| GVENSSYLVALDKLN | 486 | P42702 | |
| DADAQKNALVSYSLV | 481 | Q9UN75 | |
| YGAAVQAAILSGDKS | 371 | P11142 | |
| SSTILLAYGQVAAKA | 376 | Q6ZUA9 | |
| VLEALGSCLNNKYSE | 61 | P34896 | |
| TDAAANLTKIVAYLG | 731 | Q13423 | |
| ELINAAKGSSNSYAI | 176 | P46782 | |
| SEAFDELLASKYGLA | 81 | P41220 | |
| SAAVSLDGILSKAQY | 1921 | Q8NF91 | |
| LNSKNSGIYAAAVAV | 856 | Q6ZUX3 | |
| ASLEAVSYAIDTLKA | 146 | O96007 | |
| KDGDIDSSLVQYALL | 491 | Q5TEA6 | |
| NLDLFKGLADYVAAT | 396 | Q9NYY8 | |
| GGLYSQEQAAKAVLA | 376 | Q9NVN8 | |
| DGALAYKLLIQTGDA | 816 | Q9Y6C5 | |
| KAGDESNIIASRLYL | 596 | Q6ZW05 | |
| GKATDIYAVNGTEIL | 36 | Q8IWT1 | |
| EYKGLQLSLDQISAS | 336 | P81133 | |
| NSSLGDAINKYDVVI | 131 | Q11206 | |
| LNADAIVVKLNSGDY | 351 | Q7KZF4 | |
| YDELLAAEARAIKNG | 476 | Q7KZF4 | |
| ALEKSYDISSGLVAI | 146 | Q86UG4 | |
| SGDLYVLAADKVASV | 326 | Q9NSE4 | |
| YVDDSIALQIALGNK | 316 | Q9UQ84 | |
| VEDQLSLATTLYDKG | 616 | Q9H6W3 | |
| LLQTKNYDIGAALDT | 416 | Q13501 | |
| DTVNKALGLSTDDAY | 791 | Q9UK61 | |
| GVYVLDLAAKVDATA | 211 | P53396 | |
| GENYKTVNDIVSALL | 421 | Q13490 | |
| LQAGEYVSLGKVEAA | 586 | O95573 | |
| AGVADQTKDGLISYQ | 61 | O75746 | |
| SAYVLASLAGEELQA | 821 | O75339 | |
| IYGSAVADKLDNSRS | 136 | O95476 | |
| KAEGLINVSNYSLES | 446 | Q969H4 | |
| TSINDQLVKEGLASY | 851 | Q9BXT8 | |
| ALVYAKEQLFAEASG | 116 | Q6PCB0 | |
| AVEGLAYLTLDADVK | 531 | Q8IWX7 | |
| ISALEQYAAKVSIDG | 181 | P52747 | |
| DYLISVGADINKIDS | 326 | O75762 | |
| KQILSLNYDDSTAAG | 481 | Q12768 | |
| LAESTSQAAYLALKV | 2786 | Q8N2C7 | |
| NDDISLYKSFLQLGA | 81 | P27449 | |
| GSNYKSLEVLVADLV | 401 | P98170 | |
| ASDVEGLYAAVKALV | 1421 | Q8IZQ1 | |
| DSQLLVTASDDGYIK | 201 | Q9GZS3 | |
| AKLAQGAYRTAVDLE | 666 | P10745 | |
| LQTAGKLVADNYASA | 941 | P10745 | |
| KLVADNYASAELGAK | 946 | P10745 | |
| ASLEDQKGLVASYQV | 36 | Q02161 | |
| ASLEDQKGLVASYQV | 36 | P18577 | |
| SLGDLYAQKNSGVTA | 231 | Q13009 | |
| DQAAKLSYASAESLE | 131 | Q9C0H9 | |
| AALQSDLEDSLYKAA | 441 | Q9C0H9 | |
| TSDVLANVTYLKGEL | 701 | Q8N271 | |
| DSIEGIYDTLKQCAL | 226 | P23921 | |
| ITEGKYAALEAQAIG | 261 | Q9UHP6 | |
| AALDNTNIGKVSSYI | 1156 | Q8NDV3 | |
| SALQLLYTAKEAGGN | 1771 | Q9Y490 | |
| LYKDITSQAAGVLAQ | 106 | Q8WVD5 | |
| NADGLKDSLYVAVAD | 846 | A1X283 | |
| KLYSATVTDFLAIDA | 181 | Q9H2E6 | |
| LASEDYGKDLASVNN | 1681 | Q13813 | |
| ASDADGYVAAELLAK | 646 | Q6UWL2 | |
| LKQVSAGQTSVYALD | 1036 | Q7Z6L1 | |
| LLKTYAESGNAQAAA | 206 | Q92626 | |
| ITQALRDEKAGAYAA | 276 | Q9NRS6 | |
| ATGKLASADIETYLL | 256 | Q9UKX3 | |
| YLGEDKTSAQVSLAA | 206 | O00534 | |
| GNAYLALKNISGALE | 696 | Q96AE7 | |
| ASLLDYDTVAGADKF | 1036 | Q15393 | |
| RAAAYVSEELKAAAL | 11 | Q63HK5 | |
| KLTYGDAQNLIEAAS | 401 | O00337 | |
| YTEIKLNTDSVADGL | 236 | Q6ZNC4 | |
| EAYRNGLKTEALSVS | 1126 | Q9H582 | |
| GDLADYLQAKGTLSE | 91 | Q8IYT8 | |
| LAYATALLNEKEQSG | 2566 | Q9UPU5 | |
| AAYSAASLLVGEEFK | 206 | Q9BSR8 | |
| DEGIYLQVKSLTAAS | 1626 | Q5VWN6 | |
| LQVKSLTAASVDGAY | 1631 | Q5VWN6 | |
| QLITGKEDAASNYAR | 91 | Q6PEY2 | |
| GQLAKEEIATAIYSG | 811 | Q9NYU1 | |
| ELCKTGNAYLTAELS | 356 | Q9C040 | |
| ALFADGKLYSATVAD | 176 | Q8NFY4 | |
| YLVASNLTTNEDIKG | 301 | Q9NUE0 | |
| LAYSEVSQDGKSLLD | 496 | O75962 | |
| AAYSASLEDVKTAVL | 551 | P49815 | |
| YNGFNLIAADLSTAK | 116 | Q6ICL3 | |
| YKSDTELLGLSAQDL | 1126 | P41229 |